Polar Asset Management Partners’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Polar Asset Management Partners’s Portfolio MRTX Stock Details MRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-45,000	Closed	-$2.64M	–	971
2023 Q4	$2.64M	Buy	+45,000	New	+$2.53M	0.05%	333
2023 Q3	–	Sell	-98,500	Closed	-$3.56M	–	1020
2023 Q2	$3.56M	Buy	+98,500	New	+$4.06M	0.06%	371

Other funds holding MRTX

Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Polar Asset Management Partners's MRTX Position: Q1 2024 in Review

Polar Asset Management Partners sold out of Mirati Therapeutics, Inc. Common Stock (MRTX) in Q1 2024, closing a stake of 45,000 shares — an estimated $2.64M sold.

Polar Asset Management Partners first reported a position in MRTX in Q2 2023 and held it in 2 quarters. The position peaked at $3.56M in Q2 2023. 2 funds tracked by Wall St. Rank hold MRTX as of Q1 2024.

Polar Asset Management Partners reported no remaining Mirati Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
Polar Asset Management Partners sold 45,000 Mirati Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $2.64M.
Polar Asset Management Partners first reported a position in Mirati Therapeutics, Inc. Common Stock in Q2 2023 and held it in 2 quarters.
Polar Asset Management Partners's Mirati Therapeutics, Inc. Common Stock position peaked at $3.56M in Q2 2023.
2 funds tracked by Wall St. Rank held Mirati Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Polar Asset Management Partners's 13F filing for Q1 2024, filed 15 May 2024.